Tumor Volume Dynamics as an Early Biomarker for Patient-Specific Evolution of Resistance and Progression in Recurrent High-Grade Glioma

Recurrent high-grade glioma (HGG) remains incurable with inevitable evolution of resistance and high inter-patient heterogeneity in time to progression (TTP). Here, we evaluate if early tumor volume response dynamics can calibrate a mathematical model to predict patient-specific resistance to develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Glazar, Daniel J., Grass, G. Daniel, Arrington, John A., Forsyth, Peter A., Raghunand, Natarajan, Yu, Hsiang-Hsuan Michael, Sahebjam, Solmaz, Enderling, Heiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409184/
https://www.ncbi.nlm.nih.gov/pubmed/32605050
http://dx.doi.org/10.3390/jcm9072019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409184/
https://www.ncbi.nlm.nih.gov/pubmed/32605050
http://dx.doi.org/10.3390/jcm9072019

Ejemplares similares